Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma

Moureau-Zabotto, Laurence; Touboul, E.; Lerouge, D.; Deniaud-Alexandre, É.; Grahek, D.; Foulquier, J.N.; Petegnief, Yolande; Grès, B. Du; Balaa, Hanna El; Kerrou, K.; Montravers, F.; Keraudy, K.; Tiret, Emmanuel; Gendre, Jean–Pierre; Grangé, Jean‐Didier; Houry, S; Talbot, Jean-Noël

doi:10.1016/j.ijrobp.2005.02.039

Cited by 123 publications

(59 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In three of these patients (10%) the influence of the FDG-PET would have led to enlargement of the irradiated volume [129]. In another study, employing a coincidence scanner, use of fused FDG/CT scans altered the GTV in 19 of 34 patients (56%) [130]. …”

Section: Esophageal Cancermentioning

confidence: 97%

Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007

MacManus

Nestle

Rosenzweig

et al. 2009

Radiotherapy and Oncology

333

197

View full text Add to dashboard Cite

show abstract

Section: Esophageal Cancermentioning

confidence: 97%

Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007

MacManus

Nestle

Rosenzweig

et al. 2009

Radiotherapy and Oncology

333

197

View full text Add to dashboard Cite

show abstract

“…There is no definitive method of validating the accuracy of a registration but fixed landmark placement and ROI-based comparisons have been used [32][33]. This study applied an ROIbased method of validation, choosing structures which were easy to identify and contour, and adjacent to the treatment field.…”

Section: Discussionmentioning

confidence: 99%

Superiority of Deformable Image Co-registration in the Integration of Diagnostic Positron Emission Tomography-Computed Tomography to the Radiotherapy Treatment Planning Pathway for Oesophageal Carcinoma

et al. 2016

View full text Add to dashboard Cite

“…In patients with squamous cell carcinoma of the esophagus and some inoperable cases, 18 F-FDG PET/CT plays an important role in radiotherapy planning,39–41 with a reported modification of gross tumor volume in 56% of the patients and alteration of the planning treatment volume in 53% 41…”

Section: Methodsmentioning

confidence: 99%

¹⁸F-FDG PET/CT Imaging In Oncology

Almuhaideb

Παπαθανασίου

Bomanji

2011

Annals of Saudi Medicine

273

123

View full text Add to dashboard Cite

Accurate diagnosis and staging are essential for the optimal management of cancer patients. Positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro- D-glucose integrated with computed tomography (18F-FDG PET/CT) has emerged as a powerful imaging tool for the detection of various cancers. The combined acquisition of PET and CT has synergistic advantages over PET or CT alone and minimizes their individual limitations. It is a valuable tool for staging and restaging of some tumors and has an important role in the detection of recurrence in asymptomatic patients with rising tumor marker levels and patients with negative or equivocal findings on conventional imaging techniques. It also allows for monitoring response to therapy and permitting timely modification of therapeutic regimens. In about 27% of the patients, the course of managment is changed. This review provides guidance for oncologists/ radiotherapists and clinical and surgical specialists on the use of 18F-FDG PET/CT in oncology.

show abstract

Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma

Cited by 123 publications

References 35 publications

Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007

Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007

Superiority of Deformable Image Co-registration in the Integration of Diagnostic Positron Emission Tomography-Computed Tomography to the Radiotherapy Treatment Planning Pathway for Oesophageal Carcinoma

¹⁸F-FDG PET/CT Imaging In Oncology

Contact Info

Product

Resources

About

Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma

Cited by 123 publications

References 35 publications

Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007

Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007

Superiority of Deformable Image Co-registration in the Integration of Diagnostic Positron Emission Tomography-Computed Tomography to the Radiotherapy Treatment Planning Pathway for Oesophageal Carcinoma

18F-FDG PET/CT Imaging In Oncology

Contact Info

Product

Resources

About

¹⁸F-FDG PET/CT Imaging In Oncology